Search details
1.
A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose.
Eur J Haematol
; 2024 May 06.
Article
in English
| MEDLINE | ID: mdl-38711359
2.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35443559
3.
Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma.
Future Oncol
; 19(22): 1535-1547, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37578377
4.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Cancer
; 127(4): 609-618, 2021 02 15.
Article
in English
| MEDLINE | ID: mdl-33085090
5.
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies.
Biol Blood Marrow Transplant
; 26(4): 789-797, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31891814
6.
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes.
Biol Blood Marrow Transplant
; 26(10): 1861-1867, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32629157
7.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32062061
8.
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(8): 1459-1468, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32434056
9.
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Biol Blood Marrow Transplant
; 26(9): 1747-1756, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32464284
10.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32781289
11.
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
Biol Blood Marrow Transplant
; 26(6): 1210-1217, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32088366
12.
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 26(3): 553-561, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31726205
13.
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
Biol Blood Marrow Transplant
; 25(2): e60-e64, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30661542
14.
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
Biol Blood Marrow Transplant
; 25(3): 466-473, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30414955
15.
Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2398-2407, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31473319
16.
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(4): 683-688, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30579965
17.
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(1): 73-85, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30153491
18.
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1875-1883, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31085303
19.
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1744-1755, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31158502
20.
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
Biol Blood Marrow Transplant
; 25(7): 1325-1330, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30716454